KLF9 and neoplasm: These findings collectively establish KLF9 as a master regulator of endothelial dysfunction through distinct mechanisms: direct YAP1 activation in hyperglycemic conditions, inflammatory pathway modulation in metabolic contexts, and stress-response signaling in tumor vasculature.